Shandong Boyuan Pharmaceutical & Chemical Co Ltd

The company maintains a strong liquidity position with a current ratio of 6.71, indicating a robust ability to meet short-term obligations. However, its operating cash flow is negative at -2.97 million CNY, which may raise concerns about its ability to sustain operations without external financing. The price-to-book ratio of 5.13 suggests that the company is trading at a premium relative to its book value, potentially reflecting investor optimism about its future earnings potential. In terms of profitability, the company's return on equity (ROE) is 9.97%, which is a measure of how effectively it generates profit from shareholders' equity. This ROE is in line with the typical metrics for the pharmaceutical industry, though specific comparisons to cohort medians are not available in the provided data. The return on assets (ROA) of 8.93% indicates that the company is efficiently using its assets to generate earnings. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. Geographically, the company is based in China, and its exposure is primarily domestic, with no significant international operations disclosed. Looking at the growth trajectory, the company's revenue for the latest period is 1.46 billion CNY. While the outlook for the current and next fiscal years is not explicitly provided, the company's capital expenditure of -85.097 million CNY suggests a focus on cost management or asset reduction rather than expansion. The company faces a medium liquidity risk due to its negative operating cash flow, despite a strong current ratio. The risk assessment also notes that net cash is negative after subtracting total debt, which could indicate potential liquidity constraints. The dilution risk is assessed as low, with no immediate pressure for share issuance or dilution. There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The absence of recent transcripts or filings suggests a stable operational environment without major disruptions.